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Abstract 
The expression of mitochondrial and nuclear genes involved in ATP production was examined in renal carcinomas, renal 
oncocytomas, and a salivary oncocytoma. Renal carcinomas were found to have a reduced mitochondrial DNA (mtDNA) content while 
oncocytomas had increased mtDNA contents. This parallels morphological changes in mitochondrial number in these tumours. In the 
carcinomas, mtDNA transcripts were decreased 5- to 10-fold relative to control kidneys, suggesting that mitochondrial transcript levels 
depend on the mtDNA content. In renal oncocytomas, mtDNA transcripts were slightly reduced in spite of a high mtDNA content. 
However, in the salivary gland oncocytoma, mtDNA transcripts were increased more than 10-fold in parallel with a 10-fold increase in 
mtDNA content. The expression of the nuclear DNA oxidative phosphorylation genes, ATPsyn[3 and ANT2, was reduced up to 4-fold in 
renal carcinoma. In contrast, the levels of these two nuclear gene transcripts were induced about 4-fold in renal oncocytoma and up to 
30-fold in salivary gland oncocytoma. Moreover, the ANT2 precursors were observed to change in oncocytomas. These data suggest a
coordinated regulation of nuclear and mitochondrial gene expression i  renal carcinomas and the specific induction of nuclear OXPHOS 
gene expression i  oncocytomas. 
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1. Introduction 
A variety of tumour types have been reported to have 
an altered energy metabolism. Many tumours show an 
increase in glycolysis, while sustaining an oxidative 
metabolism. This appears to result from the association of 
hexokinase with the mitochondria [1], thus channelling 
mitochondrial ATP to the cytosol driving glycolysis. In 
many solid tumours, the altered metabolism is associated 
with reductions in mitochondria nd mtDNA levels [2,3] 
and changes in mitochondrial size and shape [2] and 
membrane potential [4,5]. In SV40-transformed iploid 
Abbreviations: OXPHOS, oxidative phosphorylation; ATPsyn13, t3 
subunit of the ATP synthase; ANT, adenine nucleotide translocator: 
GAPDH, glyceraldehyde phosphate dehydrogenase; kb,kilobase(s); bp. 
base pair(s). 
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fibroblasts as well as HeLa and EBV-transformed lympho- 
blasts, the reduction in cellular mtDNA levels is associated 
with a coordinate induction in nDNA and mtDNA OX- 
PHOS transcripts and induction of the ANT isoforms 
ANTI and ANT2 [3]. This could reflect a compensatory 
mechanism for responding to a reduced energy metabolism 
in these transformed cells. Oncocytomas tand in marked 
contrast o most other solid tumours in that they accumu- 
late large numbers of hypertrophied mitochondria occa- 
sionally containing granular deposits. This unique feature 
of oncocytomas has led to the cytological designation of 
"oxyphil tumour cell' [6-8]. The mechanism for the ex- 
traordinary proliferation of mitochondria in oncocytoma 
cells is unknown. However, it is possible that it reflects an 
induction of mitochondrial biogenesis. 
Mitochondria contain their own genome which encodes 
thirteen polypeptides involved in OXPHOS [NDI to 6 and 
ND4L, COI to COIII, ATP6 and 8, and cytochrome b (cyt 
b)], as well as the 12S and 16S ribosomal RNAs and 
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transfer RNAs required for mitochondrial protein synthesis 
[9]. The other mitochondrial proteins are encoded in the 
nucleus, translated in the cytoplasm, and imported into the 
mitochondria [10,11]. The approximately 75 nDNA OX- 
PHOS polypeptides, including the catalytic 13 subunit of 
the ATPsynthase (ATPsyn13) [12,13] which make up the 
five mitochondrial complexes (I through V), are assembled 
with the mtDNA polypeptides within the mitochondrion. 
The mitochondrial protein that exchanges ATP and ADP 
across mitochondrial internal membrane, the adenine nu- 
cleotide translocator (ANT) [14], is also nuclear encoded 
and has three isoforms: ANT1, ANT2 and ANT3. ANT1 is 
primarily expressed in heart and skeletal muscle, ANT2 
appears to facilitate ATP-ADP equilibration between the 
mitochondria nd cytosol in anaerobic ells, and ANT3 is 
expressed in all tissues [15-21]. 
To investigate the physiology of the oxyphil oncocy- 
tomas, we have examined the mRNA levels for mtDNA, 
and nDNA OXPHOS genes and compared these to renal 
carcinomas. The mitochondrial ND2, ND5/6 (complex I) 
and cyt b (complex II) transcripts were quantified in 
control kidney and salivary gland, in two renal tumours 
(carcinoma nd oncocytoma) nd in a salivary gland onco- 
cytoma. The RNA levels of the OXPHOS ANT2 and 
ATPsyn13 genes as well as of the glycolytic GAPDH gene 
were also determined in these tissues. The nuclear and 
mitochondrial transcript patterns were observed to differ in 
the various tissues, indicating that changes in energy 
metabolism are complex in these tumour tissues. 
University Hospital, Surgical Pathology, Philadelphia). The 
rest of the samples were provided with their respective 
clinical descriptions (Table 1) by Drs. Jackson Gates, MD; 
William Hardman, MD; Emma Diaz, MD; and Marian 
Pennington, MD (Department of Pathology at Emory Uni- 
versity School of Medicine, Atlanta). All biopsy samples 
used for RNA extraction were frozen immediately in liquid 
Nitrogen after the surgical excision, except he post mortem 
ONC 2, ONC 3 and their matched controls (C 4) which were 
collected within 4 h to prevent RNA degradation. The 
clinical and histological descriptions are listed on Table 1. 
2.2. Nuclear and mitochondrial probes 
The ANT2 probe was a 1200 bp XhoI /HindI I I  restric- 
tion fragment obtained from pSKHANT21 which was 
derived from subcloning the hp21 cDNA (Dr R. Baserga, 
Temple University Medical School, Philadelphia, PA) into 
pBluescript SK- (Stratagene). The ATPsyn13 probe was a 
950 bp EcoRI restriction fragment of a cDNA encompass- 
ing the C-terminal two-thirds of the coding sequence [12]. 
The GAPDH and 18S rDNA probes were full length 
cDNAs subcloned into pBluescript SK- (Stratagene). 
The specific mtDNA ND2, ND5 + ND6 and cyt b 
probes were generated by PCR amplification from 5 ng of 
HeLa DNA using primers listed in Table 2. The PCR 
conditions involved 35 cycles of I min at 93°C, 1 min at 
the hybridization temperature (Table 2) and 1 min at 72°C. 
2.3. RNA isolation and Northern blot analysis 
2. Materials and methods 
2.1. Autopsy and biopsy tissues 
Total RNAs were isolated from Kidney and salivary 
gland oncocytomas, Kidney carcinomas and their matched 
controls. ONC 2 and ONC 3 samples and their matched 
controls (Table 1) were provided and histologically exam- 
ined by Dr. Peter A. McCue MD (Thomas Jefferson 
Total cellular RNA was isolated by the guanidinium 
isothiocyanate procedure [22] from 0.2 to 0.5 g of tissue 
pulverized in liquid nitrogen (Ultra-Turrax T25). RNA 
samples (10 to 15 p~g) were denatured by incubating at 
55°C for 20 min in 1 M deionized glyoxal, 50% (v/v)  
dimethyl sulfoxide (DMSO), 10 mM NaH2PO 4 (pH 7.0), 
and electrophoresed in 1.3% agarose (Ultrapure, BRL) gels 
containing 10 mM NaH2PO 4 (pH 7.0). Gels were blotted 
overnight onto nylon membranes (Hybond-N, Amersham) 
Table 1 
Clinical and histological properties ofcarcinoma and oncocytoma biopsies 
Tumour type Matched control Age and sex Histological description 
CAR1 CI 71, M 
CAR2 C2 38, M 
CAR3 no matched control 62, F 
ONC I C3 54, M 
ONC2 C4 71, F 
ONC3 C4 71, F 
ONC4 C5 68, M 
Renal cell carcinoma, clear cell type, grade II, without capsular o  vascular 
invasion. 
Renal cell carcinoma, grade II, clear cell type. with focal venous invasion. 
Renal cell carcinoma, clear and granular cell types, nuclear grade II with 
extension i to peripheric fat. 
Renal oncocytoma, eosinophilic granular cytoplasm, enlarged and 
hyperchromatic nu lei in several reas. 
Renal oncocytoma, hypertrophied cells packed with mitochondria. 
Same as ONC 2. duplicated sample from a different autopsy region. 
Oxyphilic adenoma, superficial parotid mass. 
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Table 2 
Oligonucleotide pairs used for polymerase chain reaction amplification fmtDNA probes in Northern analysis 
205 
Primer pairs mtDNA region TH (°C) mtDNA genes 
5'-GCACCCCTCTGACATCC 3' 4831-5917 51 ND2 
5'-ccacaagcttCGGTCGGCGAACATCAGTGG 3' 
5'-ccaagcttGGGGATTGTGCGGTGTGTG 3' 
5'-CTTCTCCTATTTATGGGGGT 3' 
5'-cc aagcttCAACTACAAGAACACCAATG 3' 
5'-ccaagcttCAATTAGGGAGATAGTTGG 3' 
13 172-14606 53 ND5 + ND6 
14 728-15 865 53 cyt b 
Sequence homology with human mtDNA [9] is indicated incapital letters. 
in 20 × SSC (3 M NaC1, 0.3 M Na citrate, pH 7.0) and the 
blots were baked at 80°C for 2 hours. The RNA blots were 
prehybridized for 6 to 16 hours at 55°C (Hybaid oven) in 
5 × SSPE (3.6 M NaC1, 100 mM NazPO 4, 20 mM EDTA, 
pH 7.0), 5 × Denhardt, 50% formamide, 0.2% SDS and 
0.05% (w/v )  of sheared and denatured salmon sperm 
DNA. Hybridization was performed overnight at 42°C in 
the same buffer following addition of 6 × l06 cpm of 
32p-dCTP labelled probe [23] plus 100 mg/ml  sheared 
denatured salmon sperm DNA. Blots were washed three 
times (10 rain) in 1 × SSC and 0.1% SDS at 55°C and 
autoradiographs were obtained by exposing Amersham 
hyperfilms with intensifying screens at - 80°C for 5 h to 4 
days. Autoradiographic exposure intensities were analysed 
and quantified using a video camera and the Minichromax 
(Nautil interfaces) and Biolab A (CNRS-HEVEA) pro- 
grams. The amount of RNA blotted for each sample was 
normalized by hybridization of the Northern blots with 
human 18S rDNA probes. Synthetic control transcripts 
were loaded on gels destined for ANT hybridization to 
control for the specificity of hybridization. Synthetic RNAs 
for ANTI and ANT2 were transcribed using T7 poly- 
merase from pTZHANTl l  [15] and pSKHANT21. T3 
polymerase was used for the full length ANT3 from 
pKSFHANT3 [21]. Little if any cross-hybridization be- 
tween the ANT1 probe and the two other isoform tran- 
scripts occurred under our experimental conditions. 
2.4. DNA purification and Southern blot analysis 
Total cellular DNA was extracted from 0.1 to 0.2 g of 
tissue pulverized in liquid nitrogen. The samples were 
digested overnight with proteinase K (12 ~g/ml )  at 50°C 
in STE (10 mM Tris-HC1 pH 8.0, 100 mM NaC1, 2 mM 
EDTA and 0.6% SDS) and then with RNAse A (5 ~g/ml )  
for 60 min at 37°C. The proteins were removed by organic 
extraction followed by precipitation with 1.5 M NaC1 and 
centrifugation for 15 min at 1000 × g. 1-5 Ixg of DNA 
was digested with 15 units of BamHI, SstI or EcoRI; the 
fragments were separated on a 0.8% agarose gel, and 
transferred onto nylon membranes (Hybond-N, Amersham). 
Filters were prehybridized and hybridized as described 
above, first with the 18S DNA probe, exposed to X-ray 
film, rinsed twice for 30 min at 90°C in 1 × SSC + 0.1% 
SDS, then hybridized a second time with a total mitochon- 
drial DNA probe linearized with BamHI, and exposed to 
X-ray film. The band intensities were compared by 
densitometric analysis. 
transcript 1 2 3 4 5 6 7 8 9 10 11 12 size 
I I I I I I I I I I I I 
- - 2 .3  
Cytb  - - 1 .2  
ND?_ - 1.1 
rRNA-  - 1.9 
Fig. 1. MtDNA transcript analysis for controls, carcinomas nd oncocytomas. Northern blot autoradiographs hybridized with mtDNA and 18S rDNA 
probes. The transcripts analysed are indicated on the left and their apparent sizes on the right. Lanes 1 to 5:C1 to C5 controls; lane 6, 7 and 8 were CAR1 
to CAR3 carcinomas, respectively; anes 9 to 12 were ONCI to ONC4 oncocytomas, respectively (see experimental procedures). One of three blots 
sequentially h bridized to the four probes is presented. The blot was exposed for 12 h except for the rDNA probes (5 h). 
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3. Results 
3.1. Mitochondrial gene expression 
Quantitation of the transcript levels from the mitochon- 
drial ND2, ND5/6 and cyt b genes in control kidney, 
renal oncocytoma, renal carcinoma, control salivary gland 
and salivary gland oncocytoma revealed ifferent patterns 
of expression (Figs. 1 and 2). Data for kidney RNAs are 
the average from 2 or 3 different patients and the standard 
error is indicated (Fig. 2). For the salivary gland control 
and oncocytoma, only one sample was available. 
Comparison of the mitochondrial OXPHOS gene mRNA 
levels from two types of renal tumours to those from 
control kidneys revealed that all tumour mRNA levels 
were decreased. The reductions were most marked for the 
renal carcinoma which ranged from 5-fold for ND2 to 
10-fold for ND5. For the renal oncocytomas, the ND2 and 
ND5 mRNAs were only reduced 1.6- to 1.8-fold. In 
contrast, a comparison of the mRNA levels of the salivary 
gland oncocytoma versus control revealed a 14-fold in- 
crease for the cyt b transcript and an 18-fold increase for 
the ND2 transcript. 
3.2. Quantitation of mtDNA in DNA fractions from con- 
trols and tumour biopsies 
Table 3 
Quantitation of mtDNA versus nDNA of control and turnouts 
mtDNA nDNA mt/nDNA 
Control kidney 11.2 6.5 1,7 
Kidney oncocytoma 9 I. I 16.9 5,4 
Kidney carcinoma 7.8 22.3 0.4 
Control salivary gland 6.0 38.4 0,2 
Salivary gland oncocytoma 32.9 15.9 2. l 
The values were determined by quantitative scanning densitometry of the 
Southern blots (see Fig. 3). Data have been expressed in arbitrary units 
(rot = mitochondrial; n = nuclear) and based on one individual of each 
tumour used in this study. 
analysis of the autoradiographs howed that the 
mtDNA/18S rDNA ratio is 3-fold higher in renal oncocy- 
toma than in control kidney but is 5-fold lower in carci- 
noma (Table 3). In salivary gland oncocytoma, the 
mtDNA/! 8rDNA ratio is 10-fold higher than in control. 
The mtRNA levels were adjusted for the 
mtDNA/nDNA ratios to give a relative mitochondrial 
transcript ratios (data from Figs. 2 and 3 and Table 3). 
This revealed that relative to the template levels, the 
mitochondrial mRNA transcript levels in carcinoma were 
comparable to control kidney. The renal oncocytoma tran- 
script to template ratio was 5-fold lower than in control 
kidney, while this ratio in the salivary gland oncocytoma 
was comparable to the control salivary gland. 
The relative amounts of mtDNA in controls and tu- 
mours were determined by the ratio of the hybridization 
bands detected by the mtDNA probe versus a nuclear 18S 
rDNA probe in genomic blots (Fig. 3). The densitometric 
3.3. Nuclear OXPHOS gene expression 
The expression of the nuclear OXPHOS genes ATP- 
syn[3, ANT2, and the glycolytic GAPDH gene were also 
"E 
b 
m 
T 
I c 
~x~ ND5 ~ Cytb ~ ND2 
i 
CAR ONC I 
I I 
C ONC 1 
Kidney Salivary gland 
Fig. 2. Quantitation of the mtDNA transcripts from controls, carcinomas and oncocytomas. The values were determined by scanning densitometry of the 
Northern blots. C: control; CAR: carcinoma; ONC: oncocytoma. Data are expressed in arbitrary units normalized to the relative intensity of the 18S 
nuclear RNA band (see Fig. 1). The values for the kidney are the average from at least three different biopsies, with the bars indicating the standard 
deviation. The salivary gland values are from a single sample. 
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Kidney Salivary gland 
ONC 
I I 
I I I 
C 
I I 
I I I 
CAR 
I I I 
C ONC 
I I I I 
Size ~ ~ Size 
(kb) ~ ~ (kb) 
I I I I I I 
® 
® 
-8  - -8  
- 6.4 -- 6.4 
- 6.1 -- 6.1 
- 16.5 -- 16.5 
Fig. 3. MtDNA and nDNA analysis of controls, carcinomas and oncocytomas. Southern blot autoradiographs involving 1 to 5 Ixg of total cellular DNA 
digested with BamHI, Sstl and EcoRI. C: control; CAR: carcinoma; ONC: oncocytoma. The same filter was hybridized with a 18S rRNA nuclear probe 
(panel A), then washed and hybridized again with a total mtDNA probe (panel B). The intensities of the BamHI 16.5 kb mtDNA band and the 6.4 kb 18S 
rDNA band were quantitated (see Table 2). 
analysed in these samples (Fig. 4). The mRNA levels were 
normalized to the nuclear encoded 18S rRNA (Fig. 5). The 
specificity of  ANT2 eDNA hybridization was conf irmed 
by including in vitro transcripts from the three isoforms 
ANT I ,  ANT2 and ANT3 cDNAs  on the blots (see Section 
2). 
A 4-fold decrease of  the ATPsynl3 and ANT2 transcript 
levels was observed in renal carcinoma as compared to 
control kidney. In contrast, the levels of  these transcripts 
were increased 4-fold in the renal oncocytoma nd up to 
30-fold in the salivary gland oncocytoma. The GAPDH 
mRNA level was increased in all tumours, ranging from 
about 1.6-fold in renal oncocytoma up to 20-fold in sali- 
vary gland oncocytoma. 
Paradoxically, the level of  the ANT2 precursor which 
was detected in the autoradiographs (Fig. 4) did not paral- 
lel the mature transcript levels. The mature ANT2 mRNA 
versus ANT2 precursor mRNA ratio is similar in control 
transcript 1 2 3 4 5 
I I I I I 
preANT2 
ANT2 
6 7 8 9 10 11 12 size 
I I I I I I I (kS) 
4.8  
1.2 
ATPsynl3 1.8  
GAPDH .... 1.3 
18SrRNA - -  --  1.9 
Fig. 4. Nuclear OXPHOS gene transcripts from controls, carcinomas and oncocytomas. Northern blot autoradiographs hybridized with the nuclear ANT2, 
ATPsynl3, GAPDH and 18S rDNA probes. The probes used are listed on the left and their apparent transcript sizes on the right, preANT2:ANT2 
unprocessed transcript. Lanes 1 to 5: CI to C5 controls; lane 6, 7 and 8 were CARl to CAR3 carcinomas, respectively; lanes 9 to 12 were ONCI to ONC4 
oncocytomas, respectively (see experimental procedures). One of the three blots sequentially hybridized with the four probes is presented. The blot was 
exposed for 12 h except for the rDNA probes (5 h). 
16 
m ,~ f f - - - l  
14 
"~= 12 
6 
4 
2 
ANT2 [~ GAPDH ~7~ ATPsyn~ 
I 
I I 
C CAR 
I 
0 I I I 
ONC 
I 
Kidney 
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C ONC 
Salivary gland 
Fig. 5. Quantitation of nuclear OXPHOS gene transcripts from controls, carcinomas and oncocytomas. The values were determined by quantitative 
scanning densitometry of the Northern blots. C: control; CAR: adenocarcinoma; ONC: oncocytoma. Data are expressed in arbitrary units normalized to the 
relative intensity of the 18S nuclear RNA band (see Fig. 4), The values for the kidney are the average of at least three different biopsies with the standard 
deviations hown. The salivary gland data was from a single determination. 
kidney, control salivary glands and renal carcinoma. How- 
ever, this ratio was increased 4-fold in renal oncocytoma 
and 30-fold in salivary gland oncocytoma relative to the 
corresponding control tissues. 
4. Discussion 
Analysis of the mitochondrial and nuclear OXPHOS 
gene transcripts in renal carcinomas, renal and salivary 
gland oncocytomas relative to controls revealed that the 
mtDNA ND2, ND5 and cyt b transcripts were substan- 
tially decreased in the renal carcinomas, only slightly 
reduced in renal oncocytomas, but increased in salivary 
gland oncocytoma. Furthermore, changes in the expression 
of the nuclear OXPHOS genes for ATPsyn[3 and ANT2, 
parallelled the changes in mtDNA OXPHOS gene expres- 
sion. 
These changes in mtDNA transcript levels were associ- 
ated with changes in the relative levels of tumour cell and 
control mtDNAs. The renal carcinomas were found to have 
a 4-fold reduction in mtDNA number as compared to 
control kidney, whereas the renal oncocytoma cells had a 
3-fold increase in their mitochondrial DNA content. Simi- 
larly, the salivary gland oncocytoma had a 10-fold increase 
in mtDNA content. The mtRNA/mtDNA ratios in both 
the renal carcinoma nd salivary gland oncocytoma were 
comparable to control ratios. However, the renal oncocy- 
toma ratio was significantly less than controls, suggesting 
a change in mtDNA transcription or mitochondrial mRNA 
stability. 
The nuclear OXPHOS gene transcript levels parallelled 
the mtDNA content as well. The renal carcinomas showed 
a substantial reduction in ATPsynl3 and ANT2 transcript 
levels, but an increase of the glycolytic GAPDH transcript. 
This is consistent with the reduced levels of renal carci- 
noma mtDNAs and the well-documented reduction in 
mitochondriai content in most solid tumours [2]. By con- 
trast, the ATPsyn[3 and ANT2 mRNA levels were elevated 
in the renal and salivary gland oncocytomas in parallel 
with their increased mtDNA content and proliferation of 
abnormal mitochondria [24-27]. A high ANT3 (ANT con- 
stitutive isoform) transcript level corroborates this high 
mitochondrial biogenesis (Stepien, unpublished observa- 
tion). 
The induction of OXPHOS genes has previously been 
observed in cultured cells immortalized by viruses or 
cellular oncogenes [28,3], as consequences of mtDNA 
damage in ischemic hearts [29], and also in presence of a 
high percentage of mutated mtDNA in tissues of patients 
with mitochondrial myopathies [30,31]. This is similar to 
the induction seen in the oncocytomas and suggests that 
nuclear regulatory factors such as those binding the 
OXBOX and REBOX motifs [32-34] could play a role in 
altering the OXPHOS gene expression. 
The reduction in mitochondrial transcript levels in the 
renal carcinoma indicates that other factors also could play 
an important role in the cancer cell energy metabolism. 
One of these factors could be the difference in the rate of 
division between mitochondrial nd nuclear systems. An- 
other could be a change in the regulation of the glycolytic 
and oxidative nergy genes. The high level of the GAPDH 
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expression suggests that the cell metabolism have switched 
to a glycolytic status. This metabolic switch might be 
associated with a decrease in nuclear ATPsynl3 transcrip- 
tion in carcinoma. 
Since the proposed role of the ANT2 isoform is to 
transport glycolytic ATP from the cytoplasm into the 
mitochondrial matrix [21] during times of OXPHOS defi- 
ciency, the high ANT2 transcript levels in oncocytomas 
would be consistent with nonfunctional mitochondria. 
ANT2 induction was also observed in Kearns-Sayre syn- 
drome tissues (liver, kidney, brain) which exhibit 65% to 
86% of deleted mitochondria [31]. Whereas most of ANT2 
RNA is in the precursor (unspliced) form in renal carci- 
noma, more than 50% is in the mature form in oncocy- 
toma, suggesting a higher requirement for cytosolic ATP 
to maintain mitochondrial proliferation in oncocytomas. 
The discovery of clear changes in OXPHOS gene ex- 
pression in solid tumours provides the opportunity to study 
the molecular mechanisms involved in energetic processes 
of cancer cells. Further, molecular investigations in nuclear 
OXPHOS gene promoters hould lead to identify cis and 
trans elements regulating ene expression during the neo- 
plastic transformation. 
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